Your browser doesn't support javascript.
loading
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt, A; Papp, K; Gottlieb, A; Jarell, A; Reich, K; Maari, C; Gordon, K B; Ferris, L K; Langley, R G; Tada, Y; Lima, R G; Elmaraghy, H; Gallo, G; Renda, L; Park, S Y; Burge, R; Bagel, J.
Affiliation
  • Blauvelt A; Oregon Medical Research Center, Portland, OR, U.S.A.
  • Papp K; Probity Medical Research, Inc., Waterloo, Ontario, Canada.
  • Gottlieb A; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.
  • Jarell A; Northeast Dermatology Associates, Portsmouth, NH, U.S.A.
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Maari C; Skinflammation® Center, Hamburg, Germany.
  • Gordon KB; Innovaderm Research, Montreal, QC, Canada.
  • Ferris LK; Medical College of Wisconsin, Milwaukee, WI, U.S.A.
  • Langley RG; Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, U.S.A.
  • Tada Y; Dalhousie University, Halifax, Nova Scotia, Canada.
  • Lima RG; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Elmaraghy H; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Gallo G; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Renda L; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Park SY; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Burge R; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Bagel J; Eli Lilly and Company, Indianapolis, IN, U.S.A.
Br J Dermatol ; 182(6): 1348-1358, 2020 06.
Article in En | MEDLINE | ID: mdl-31887225

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Br J Dermatol Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Br J Dermatol Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom